User login
- /content/obinutuzumab-based-regimens-yield-durable-remissions-cll
- /fedprac/article/192859/cll/obinutuzumab-based-regimens-yield-durable-remissions-cll
- /hematologynews/article/192859/cll/obinutuzumab-based-regimens-yield-durable-remissions-cll
- /fedprac/avaho/article/192859/cll/obinutuzumab-based-regimens-yield-durable-remissions-cll
- /hematology-oncology/article/192859/cll/obinutuzumab-based-regimens-yield-durable-remissions-cll
- /b-cell-lymphoma-icymi/article/192859/cll/obinutuzumab-based-regimens-yield-durable-remissions-cll